Padagis Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PADAGIS US
PADAGIS US has ninety-two approved drugs.
There is one US patent protecting PADAGIS US drugs.
Summary for Padagis Us
| US Patents: | 1 |
| Tradenames: | 68 |
| Ingredients: | 63 |
| NDAs: | 92 |
| Patent Litigation for Padagis Us: | See patent lawsuits for Padagis Us |
| PTAB Cases with Padagis Us as petitioner: | See PTAB cases with Padagis Us as petitioner |
Drugs and US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 204627-001 | Apr 29, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Padagis Us | LOTEPREDNOL ETABONATE | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 215204-001 | Jan 29, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | CLOTRIMAZOLE | clotrimazole | TROCHE/LOZENGE;ORAL | 076763-001 | Oct 28, 2005 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | AZELASTINE HYDROCHLORIDE | azelastine hydrochloride | SPRAY, METERED;NASAL | 202609-001 | Mar 17, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Padagis Us | CICLOPIROX | ciclopirox | GEL;TOPICAL | 078266-001 | Jan 7, 2009 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | CLOBETASOL PROPIONATE | clobetasol propionate | GEL;TOPICAL | 075027-001 | Oct 31, 1997 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 4,078,071 | ⤷ Start Trial |
| Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | 6,013,657 | ⤷ Start Trial |
| Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | 6,299,900 | ⤷ Start Trial |
| Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 6,899,890 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 5,993,856 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 5,266,329 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for PADAGIS US drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Enteric Coated Capsules | 3 mg | ➤ Subscribe | 2008-02-01 |
| ➤ Subscribe | Vaginal Cream | 2% | ➤ Subscribe | 2015-02-05 |
International Patents for Padagis Us Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2005027807 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2007079390 | ⤷ Start Trial |
| Canada | 2635992 | ⤷ Start Trial |
| Brazil | PI0620905 | ⤷ Start Trial |
| European Patent Office | 1667619 | ⤷ Start Trial |
| Singapore | 146638 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Padagis Us Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2435024 | 132021000000095 | Italy | ⤷ Start Trial | PRODUCT NAME: UNA COMBINAZIONE DI FORMOTEROLO (INCLUSI SUOI SALI, ESTERI, SOLVATI O ENANTIOMERI FARMACEUTICAMENTE ACCETTABILI), GLICOPIRROLATO (INCLUSI SUOI SALI, ESTERI, SOLVATI O ENANTIOMERI FARMACEUTICAMENTE ACCETTABILI) E BUDESONIDE (INCLUSI SUOI SALI, ESTERI, SOLVATI O ENANTIOMERI FARMACEUTICAMENTE ACCETTABILI)(TRIXEO AEROSPHERE); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1498, 20201210 |
| 1267866 | C300583 | Netherlands | ⤷ Start Trial | PRODUCT NAME: GLYCOPYRRONIUM EN ALLE DOOR HET BASISOCTROOI BESCHERMDE; REGISTRATION NO/DATE: EU/1/12/788/001-006 20120928 |
| 1267866 | 122014000025 | Germany | ⤷ Start Trial | PRODUCT NAME: GLYCOPYRRONIUM ODER EIN SALZ ODER DERIVAT HIERVON (KOMPONENTE 1) UND INDACATEROL ODER EIN DERIVAT HIERVON ODER EIN SALZ VON INDACATEROL ODER EINEM DERIVAT HIERVON (KOMPONENTE 2); REGISTRATION NO/DATE: EU/1/13/862 20130919 |
| 2435025 | 300995 | Netherlands | ⤷ Start Trial | PRODUCT NAME: COMBINATIE VAN GLYCOPYRRONIUM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF ESTER, IN HET BIJZONDER GLYCOPYRRONIUYM BROMIDE, EN FORMOTEROL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF ESTER, IN HET BIJZONDER FORMOTEROL FUMARAAT DIHYDRAAT; REGISTRATION NO/DATE: EU/ 1/18/1339 20181220 |
| 1267866 | 2013/014 | Ireland | ⤷ Start Trial | PRODUCT NAME: GLYCOPYRRONIUM OR A SALT THEREOF; REGISTRATION NO/DATE: EU/1/12/788/001-006 20120928 |
| 2515855 | CA 2018 00002 | Denmark | ⤷ Start Trial | PRODUCT NAME: A COMBINATION OF GLYCOPYRRONIUM BROMIDE, FORMOTEROL OR A SALT THEREOF, INCLUDING FORMETOROL FUMARATE DIHYDRATE AND BECLOMETASONE DIPROPIONATE; REG. NO/DATE: EU/1/17/1208 20170719 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
